SKG-0402

N/A

Report date: 2025/01/26 15:15:46

Base Information

Drug NameSKG-0402
Drug Alias NameAAV9-GLA gene therapy (Skyline therapeutics)GLA gene therapy (Skyline therapeutics)adeno-associated viral vector-based GLA gene therapy (Skyline therapeutics)SKG-0402
ClassificationBiologics
Mechanisms of Actionα-Galactosidase stimulants
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSkyline Therapeutics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSkyline Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A